Used primarily in pharmaceutical research and development, this compound serves as a key intermediate in the synthesis of biologically active molecules. Its structure, featuring a trifluoromethyl group and a tetrahydro-1,6-naphthyridine core, makes it valuable for designing drugs targeting various diseases, particularly in the fields of oncology and neurology. The compound's ability to modulate enzyme activity and receptor interactions is leveraged in the creation of potential therapeutic agents, including kinase inhibitors and central nervous system (CNS) drugs. Additionally, its hydrochloride salt form enhances solubility, facilitating its use in experimental formulations and preclinical studies.